Biologicals and vaccine specialist CSL Ltd is set to acquire Swiss Vifor Pharma Ltd for CHF10.9bn.
Up To Date
Latest News
German Apogenix AG has received a €26m in funding for a pivotal Phase III study of its CD95 ligand blocker...
The 2021 spin out of London-based Francis Crick Institute is the very first UK company formation deal of life...
Italian pharma company Recordati is putting €750m on the table to acquire UK-based specialty pharmaceutical...
Sanofi is strengthening its vaccine business by acquiring an Austrian company. The French pharma group is...
US cell & gene therapy manufacturer Orgenesis Inc. announced that its joint venture with Theracell Advanced...